Scopolamine Patch, Extended Release
Product Images NDC 50742-505

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 50742-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Figure003)

An instructional illustration showing two hands peeling apart the layers of a transdermal patch, revealing its inner adhesive side. This diagram likely demonstrates how to properly remove the protective backing of the patch before application.*

FDA Label Image

Image Description (Figure01)

An illustration diagram of a Scopolamine 1 mg extended-release transdermal patch showing its clear disposable plastic release liner with stipples, metallic adhesive surface, and tan backing membrane printed with the text 'Scopolamine 1 mg/3 days.'*

FDA Label Image

Image Description (Figure2)

An instructional diagram showing how to open the pouch of the Scopolamine transdermal patch by tearing along the dashed lines.*

FDA Label Image

Image Description (Figure4)

An instructional diagram showing a person peeling the clear, disposable plastic release liner with stipples off a scopolamine transdermal patch. The patch features an imprinted tan-colored transdermal system and a metallic adhesive surface.*

FDA Label Image

Image Description (Figure5)

An instructional illustration depicting the placement of a Scopolamine 1.5 mg extended-release transdermal patch behind the ear on the side of the head. The diagram points to the patch, labeled as an "imprinted tan-colored transdermal system."*

FDA Label Image

1 Patch Front (Image0001)

Scopolamine Transdermal System patch, 1 mg strength delivering over 3 days, from Ingenus Pharmaceuticals, LLC. The label includes instructions to wash hands immediately after application due to eye irritation risk. The package contains one transdermal system patch for prescription use.*

FDA Label Image

4 Patches (Image0002)

Packaging label for Scopolamine Transdermal System 1 mg/3 days, an extended-release patch by Ingenus Pharmaceuticals, LLC. The label displays the product name, dosage strength, indication for motion sickness and post-operative nausea and vomiting prevention, and a package count of 4 transdermal systems. It includes usage instructions, cautionary notes, and storage information alongside barcodes and manufacturer details.*

FDA Label Image

10 Patches (Image0003)

Scopolamine Transdermal System 1 mg/3 days, extended-release transdermal patch packaging from Ingenus Pharmaceuticals, LLC. The label shows a box containing 10 transdermal systems. It highlights the product's use for motion sickness and post-operative nausea and vomiting prevention. Important usage and storage information is displayed, along with serialization and barcode details.*

FDA Label Image

24 Patches (Image0004)

The packaging label for Scopolamine Transdermal System 1 mg/3 days by Ingenus Pharmaceuticals, LLC includes product name, strength, dosage form as a patch for transdermal use, and quantity of 24 transdermal systems. The label also indicates the product is for prescription use (Rx only) and references motion sickness and postoperative nausea and vomiting prevention. The label features storage and usage instructions along with barcodes and a logo for Ingenus.*

FDA Label Image

1 Patch Back (Image0005)

Text panel for Scopolamine transdermal system 1.5 mg delivering approximately 1 mg over 3 days. Includes inactive ingredients, detailed dosage and administration instructions, caution warnings, storage conditions, and manufacturer information from Ingenus Pharmaceuticals, LLC. Also features a barcode and instructions for safe use and handling.*

FDA Label Image

Structure (Structuralformula001)

Chemical structure of scopolamine, showing its bicyclic tropane ring system with an attached epoxide group and a phenylacetate moiety.*

FDA Label Image

System (System001)

A labeled cross-sectional diagram illustrating the layers of a Scopolamine transdermal extended-release patch. From top to bottom, the layers are identified as Backing Membrane, Drug in Adhesive Layer, Rate Controlling Membrane, Drug in Adhesive Layer, and Release Liner.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.